Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chuwang Wang"'
Autor:
Kewa Gao, Priyadarsini Kumar, Elizabeth Cortez-Toledo, Dake Hao, Lizette Reynaga, Melanie Rose, Chuwang Wang, Diana Farmer, Jan Nolta, Jianda Zhou, Ping Zhou, Aijun Wang
Publikováno v:
Stem Cell Research & Therapy, Vol 10, Iss 1, Pp 1-15 (2019)
Abstract Background Hemophilia A (HA) is an X-linked recessive disorder caused by mutations in the Factor VIII (FVIII) gene leading to deficient blood coagulation. As a monogenic disorder, HA is an ideal target for cell-based gene therapy, but succes
Externí odkaz:
https://doaj.org/article/f9f0ba576f85438f91539e99b05fde65
Autor:
Priyadarsini Kumar, Kewa Gao, Chuwang Wang, Christopher Pivetti, Lee Lankford, Diana Farmer, Aijun Wang
Publikováno v:
Cell Transplantation, Vol 27 (2018)
Hemophilia A (HA) is an X-linked recessive disorder caused by mutations in the factor VIII ( FVIII ) gene leading to deficient blood coagulation. The current standard of care is frequent infusions of plasma-derived FVIII or recombinant B-domain-delet
Externí odkaz:
https://doaj.org/article/de12e95972534e969c84f7d237b2a0ac
Autor:
Jan A. Nolta, Ping Zhou, Jianda Zhou, Chuwang Wang, Lizette Reynaga, Diana L. Farmer, Aijun Wang, Priyadarsini Kumar, Elizabeth Cortez-Toledo, Dake Hao, Kewa Gao, Melanie Rose
Publikováno v:
Stem Cell Research & Therapy
Stem cell research & therapy, vol 10, iss 1
Stem Cell Research & Therapy, Vol 10, Iss 1, Pp 1-15 (2019)
Stem cell research & therapy, vol 10, iss 1
Stem Cell Research & Therapy, Vol 10, Iss 1, Pp 1-15 (2019)
Background Hemophilia A (HA) is an X-linked recessive disorder caused by mutations in the Factor VIII (FVIII) gene leading to deficient blood coagulation. As a monogenic disorder, HA is an ideal target for cell-based gene therapy, but successful trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f771f4675d4c441bc1eb18945f63e531
https://doi.org/10.1186/s13287-019-1138-8
https://doi.org/10.1186/s13287-019-1138-8
Autor:
Kewa Gao, Priyadarsini Kumar, Cortez-Toledo, Elizabeth, Dake Hao, Reynaga, Lizette, Rose, Melanie, Chuwang Wang, Farmer, Diana, Nolta, Jan, Jianda Zhou, Zhou, Ping, Aijun Wang
Table S1. (1) Primer sequence of RT-PCR. (2) Primer sequence of EndMT. (3) Primer sequence of Real-time PCR. Figure S1. Characterization of the transduced cord blood ECFCs. Figure S2. Characterization of the transduced PMSCs. Figure S3. Short-term mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2312afa7e6b820f57b05d694823b2748
Autor:
Chuwang Wang, Lee Lankford, Kewa Gao, Aijun Wang, Christopher D. Pivetti, Priyadarsini Kumar, Diana L. Farmer
Publikováno v:
Cell transplantation, vol 27, iss 1
Cell Transplantation
Cell Transplantation, Vol 27 (2018)
Cell Transplantation
Cell Transplantation, Vol 27 (2018)
Hemophilia A (HA) is an X-linked recessive disorder caused by mutations in the factor VIII ( FVIII) gene leading to deficient blood coagulation. The current standard of care is frequent infusions of plasma-derived FVIII or recombinant B-domain-delete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fec77c9e6306c055ee7117fa194d9d5f
https://escholarship.org/uc/item/1n03r6kt
https://escholarship.org/uc/item/1n03r6kt
Autor:
Lizette Reynaga, Priyadarsini Kumar, Chuwang Wang, Jan A. Nolta, Ping Zhou, Dake Hao, Kewa Gao, Aijun Wang, Elizabeth Cortez-Toledo, Melanie Rose, Jianda Zhou, Diana L. Farmer
Publikováno v:
SSRN Electronic Journal.
Hemophilia A (HA) is an X-linked recessive disorder caused by mutations in the Factor VIII (FVIII) gene leading to deficient blood coagulation. As a monogenic disorder, HA is an ideal target for cellbased gene therapy, but successful treatment has be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ccb6c0b64526f1e580ca1bb4e3d1d6e
https://doi.org/10.2139/ssrn.3247846
https://doi.org/10.2139/ssrn.3247846